Latest news for IMV (OTC:IMVIF) Stock

IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

IMV Inc

WIIM

Shares of fertilizer and potash stocks are trading higher on reports suggesting potash supplier Belaruskali cut production

Wall Street&#8217;s biggest players moved to protect themselves against tech stock dominance in 2024, driving record cash into a fund that splits money evenly across all S&amp;P 500 stocks.
The Invesco<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/12/42717758/chamath-palihapitiya-says-sp-500-index-etfs-need-to-be-fixed-or-they-will-end-in-disaster-here-is-what-the-billionaire-investor-said"> S&amp;P 500 Equal Weight exchange-traded fund</a> pulled in $17 billion last year, with $14.4 billion flowing in during the final six months alone, the Financial Times said, citing Morningstar data. The surge pushed the fund&#8217;s total assets above $72 billion, making it one of the 25 largest U.S. ETFs.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
</ul>
Money poured in despite the fund&#8217;s weak performance. While the S&amp;P 500 jumped 24% last year, the equal-weight version rose just 11%. The gap stems from the outsized impact of the Magnificent Seven tech stocks – Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla – which drove about half of the S&amp;P&#8217;s gains.
&#8220;Investors&#8217; biggest focus recently has been concentration risk, worries that the market is too top-heavy,&#8221; Manish Kabra, head of U.S. equity strategy at Société Générale, said to the Financial Times.
The fund rebalances quarterly, selling market leaders and buying laggards to maintain equal positions across all holdings. The strategy paid off in 2022&#8217;s tech sell-off but lagged in 2024&#8217;s tech rally.
See Also: According to Juniper Research, the total value of B2B cross-border payments stored on the blockchain is projected to exceed $4.4 trillion — <a href="https://www.benzinga.com/money/web3-enabler-future-of-enterprise-transactions">Join the first company to bring blockchain payments to Salesforce early with just $100.</a>
Traders also turned to derivatives to guard against tech stock drops. CME Group&#8217;s S&amp;P 500 equal-weight futures contract, launched in February, now trades $2.4 billion worth of open positions.
&#8220;I think that woke some more clients up in terms of how to manage that risk and what kind of strategies they should put in place,&#8221; said Paul Woolman, CME&#8217;s global head of equity products, referring to tech stock volatility last summer.
The equal-weight rush marks part of a banner year for Invesco. Bloomberg data shows that the firm&#8217;s U.S. ETFs took in $86 billion in 2024, outpacing its previous record of $54 billion in 2021. This pushed Invesco into third place for ETF flows, behind only industry giants Vanguard and BlackRock.
Trending: With 100+ historic trademark victories, this company holds IP for some of the highest-grossing characters in history. Now, they've propelled these icons into the future using next-gen patented AR, VR, and AI technology. <a href="https://www.benzinga.com/money/elf-labs-1">There&#8217;s now a limited window for investors to claim shares at just $2/share with $980 minimum—but the clock is ticking.</a>
Some market watchers warn against the equal-weight approach. &#8220;Incorporating fundamentals in the assessment of each company would better serve investors than arbitrarily making them all equal weights,&#8221; Bryan Armour, director of passive strategies research at Morningstar, said to the Financial Times.
According to Rick de los Reyes, portfolio manager at <a href="https://www.benzinga.com/topic/t-rowe-price">T. Rowe Price</a>, the shift could boost long-neglected market sectors. &#8220;There&#8217;s some excitement around the parts of the market that have been left behind and the view that you could finally start to see some strength,&#8221; he said.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a></li>
</ul>

Markets

Investors Hedge $17 Billion Against Big Tech, Driving Record Into Equal-Weight ETF

WKSP

Worksport shares are trading higher after the company's subsidiary Terravis Energy introduced an AI-enhanced heat pump for home climate control.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Wednesday.
The Dow traded up 0.30% to 44,159.42 while the NASDAQ rose 1.48% to 20,049.15. The S&amp;P 500 also rose, gaining, 0.83% to 6,099.61.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43123084/top-3-health-care-stocks-that-could-blast-off-this-quarter">Top 3 Health Care Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Information technology shares surged by 2% on Wednesday.
In trading on Wednesday, real estate shares fell by 1%.
Top Headline
Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) posted better-than-expected second-quarter financial results.
The company reported second-quarter sales growth of 2% year-on-year to $21.9 billion, beating the analyst consensus estimate of $21.542 billion. Adjusted EPS of $1.88 beat the consensus estimate of $1.86.
P&amp;G maintained its guidance range for FY25 organic sales growth of 3%-5% and all-in sales growth of 2%-4%. P&amp;G maintained its FY25 EPS growth outlook of 10%-12% versus an EPS of $6.02 in FY24.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Blackboxstocks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares shot up 69% to $2.86 after the company announced a $250K securities purchase agreement and is anticipating a potential merger.</li>
<li>Shares of Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>)got a boost, surging 27% to $4.0950 after Needham initiated coverage with a Buy rating and a $9 price target.</li>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) shares were also up, gaining 49% to $0.7322 after the company announced it developed a new class of GLP-1 therapies using its LENS platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) shares dropped 20% to $101.25 after the company reported worse-than-expected third-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Shares of Hepion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) were down 59% to $0.13 after the company announced a $9 million public offering.</li>
<li>Lisata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) was down, falling 23% to $3.02 after the company announced preliminary cohort data from its Phase 2 Ascend trial.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $75.49 while gold traded up 0.3% at $2,768.10.
Silver traded down 0.6% to $31.320 on Wednesday, while copper fell 0.9% to $4.3015.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 surged 0.49%, Germany's DAX 40 rose 1.16% and France's CAC 40 gained 0.82%. Spain's IBEX 35 Index fell 0.41%, while London's FTSE 100 fell 0.02%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 1.58%, China's Shanghai Composite Index falling 0.89%, Hong Kong's Hang Seng Index falling 1.63% and India's BSE Sensex gaining 0.75%.
Economics
U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43125507/apple-to-183-here-are-10-top-analyst-forecasts-for-wednesday">Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Earnings

Equities

News

Eurozone

Commodities

Trading Ideas

ABSI

AGYS

BLBX

HEPA

LSTA

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings

Stephens &amp; Co. analyst Sudan Loganathan reiterates Bicycle Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>) with a Equal-Weight and maintains $15 price target.

Price Target

Reiteration

Analyst Ratings

BCYC

Stephens & Co. Reiterates Equal-Weight on Bicycle Therapeutics, Maintains $15 Price Target

Piper Sandler analyst Matt Farrell reiterates Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Overweight and raises the price target from $950 to $1100.

NFLX

Piper Sandler Reiterates Overweight on Netflix, Raises Price Target to $1100

Stephens &amp; Co. analyst Russell Gunther reiterates Pinnacle Finl Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) with a Overweight and maintains $142 price target.

PNFP

Stephens & Co. Reiterates Overweight on Pinnacle Finl Partners, Maintains $142 Price Target

Stephens &amp; Co. analyst Terry McEvoy reiterates Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) with a Equal-Weight and maintains $37.5 price target.

PEBO

Stephens & Co. Reiterates Equal-Weight on Peoples Bancorp, Maintains $37.5 Price Target

<a href="https://www.hollywoodreporter.com/business/business-news/netflix-bites-las-vegas-restaraurant-mgm-grand-opening-1236114520/">https://www.hollywoodreporter.com/business/business-news/netflix-bites-las-vegas-restaraurant-mgm-grand-opening-1236114520/</a>
&nbsp;
<a href="https://www.hollywoodreporter.com/t/las-vegas/">Las Vegas</a>‘ newest residency isn't a musical act, it's an opportunity to taste everything <a href="https://www.hollywoodreporter.com/t/netflix/">Netflix</a> has to offer.
Netflix says that it will open its latest experiential project on the casino floor at the MGM Grand in Las Vegas Feb. 20: A new outpost of its "Netflix Bites" full service restaurant.
Netflix first tested out the food concept in Los Angeles in 2023, but while <a href="https://www.hollywoodreporter.com/business/business-news/netflix-restaurant-los-angeles-curtis-stone-1235514246/">that experience</a> lasted about six weeks and was focused mostly on dinner service, the new Netflix Bites is being described as a "residency," a longer-term project than the L.A. popup.

'Netflix to Open Restaurant in Las Vegas Next Month As Live Experiences Business Expands' - Hollywood Reporter

Piper Sandler analyst Nathan Race maintains Peoples Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEBO#NASDAQ">PEBO</a>) with a Overweight and raises the price target from $39 to $40.

Piper Sandler Maintains Overweight on Peoples Bancorp, Raises Price Target to $40

President Donald Trump announced a $500 billion initiative to supercharge the <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence infrastructure</a> in the United States Tuesday. Flanked by tech titans OpenAI CEO Sam Altman, SoftBank CEO Masayoshi Son, and Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) Chairman Larry Ellison, Trump revealed the creation of a new company, Stargate, which he described as "the largest AI infrastructure project in history." 
Naturally, investors wasted no time <a href="https://www.benzinga.com/25/01/43111153/nvidia-and-ai-stock-rises-as-trump-announces-500-billion-stargate-ai-infrastructure-venture">reacting to the announcement</a>. Oracle, Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Arm Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NYSE">ARM</a>) saw notable gains, while analysts predict the dominance of AI leaders <a href="https://www.benzinga.com/etfs">like those included in</a> the Invesco Top QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QBIG#NASDAQ">QBIG</a>) will continue into 2025.
Invesco Top QQQ, an actively managed ETF tied to the Nasdaq-100 Mega Index, holds stocks from the Magnificent Seven, including AI giants like Nvidia, along with semiconductor leader Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>). This ETF is poised to capitalize on the rising demand for AI infrastructure, as semiconductor companies like Broadcom gain prominence.
Morgan Stanley analyst Ed Stanley notes that companies that strategically adopt AI—particularly those in software and finance—are likely to outperform, creating a fertile ground for ETFs like Invesco Top QQQ to thrive.
Apart from the Invesco Top QQQ ETF, which debuted in December, other notable beneficiaries of this AI boom are existing ETFs like Global X Robotics &amp; AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>) and Roundhill Generative AI &amp; Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHAT#NYSE">CHAT</a>). 
Here's a closer look at the potential winners:
Global X Robotics &amp; Artificial Intelligence ETF, known for its focus on automation and robotics companies, holds stocks of companies like Nvidia. The ETF can benefit from increased demand for hardware supporting AI infrastructure.
Roundhill Generative AI &amp; Technology ETF invests particularly in companies developing infrastructure, and software that breathe life into AI. As a fund targeting the generative AI, this ETF&#8217;s holdings in companies like Microsoft and Meta.
Stargate's Ambitious Vision
Stargate plans to invest an initial $100 billion, with a long-term vision of funneling up to $500 billion into building data centers and other critical infrastructure to support AI development. The project, already under construction in Texas, aims to create 100,000 jobs and establish the U.S. as a leader in AI technology.
Ellison noted that the group's first 1 million-square-foot data center is already underway, emphasizing the need for robust infrastructure to power next-generation AI applications. Altman agreed, calling the project "the most important of this era."
Meanwhile, Elon Musk <a href="https://www.benzinga.com/markets/equities/25/01/43121798/elon-musk-says-project-stargate-doesnt-actually-have-the-money-after-trump-announces-500-billion-ai-investment-led-by-softbank-oracle-and-openai">voiced concerns over</a> Project Stargate's funding, suggesting that SoftBank has secured far less than the ambitious $500 billion investment target.
ETFs focused on AI and technology offer a wise entry point for those looking to jump on the bandwagon. With $175 billion reportedly awaiting deployment into AI projects, the U.S. should attract significant global capital.
See Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/43128141/tech-stocks-rise-after-trump-announces-ai-infrastructure-investment">Tech Stocks Rise After Trump Announces AI Infrastructure Investment</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Tech

ETFs

AVGO

BOTZ

CHAT

NVDA

ORCL

QBIG

Trump's $500 Billion Stargate AI Plan Puts 3 ETFs In Focus

Stephens &amp; Co. analyst Terry McEvoy reiterates Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) with a Overweight and maintains $27 price target.

Stephens & Co. Reiterates Overweight on Old National, Maintains $27 Price Target

DXST

Trading Halt: Halt status updated at 11:50:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Piper Sandler analyst Nathan Race maintains Nicolet Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIC#NYSE">NIC</a>) with a Neutral and raises the price target from $119 to $120.

Piper Sandler Maintains Neutral on Nicolet Bankshares, Raises Price Target to $120

PAPL

Pineapple Financial shares are trading higher on possible continued strength after the company reported Q1 financial results yesterday. D. Boral Capital maintained a Buy rating on the stock.

Stephens &amp; Co. analyst Terry McEvoy reiterates KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) with a Overweight and maintains $20 price target.

Stephens & Co. Reiterates Overweight on KeyCorp, Maintains $20 Price Target

Piper Sandler analyst Patrick Moley reiterates Interactive Brokers Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) with a Overweight and raises the price target from $200 to $210.

IBKR

Piper Sandler Reiterates Overweight on Interactive Brokers Gr, Raises Price Target to $210

Rumors

Watching Kohl's; Traders Circulate Unconfirmed Rumor From Research Blog Suggesting The Co May File For Bankruptcy

Arabica coffee futures have soared past $3.35 per pound in January 2025, holding near multi-decade highs after peaking at $3.48 in December, the highest <a href="https://www.benzinga.com/markets/commodities">level since April 1977.</a>
In a note shared Wednesday, Bank of America analyst Sara Senatore said, &#8220;Coffee remains inflationary. For Q1 2025, average coffee price inflation is expected to be 75.5%.&#8221; 
She added that prices have surged 120% from 2023 lows, increasing investor concerns about Starbucks Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NYSE">SBUX</a>)&#8217; margins and pressuring the company's valuation multiple.
<h3 class="wp-block-heading">Chart: Coffee Futures Hover At Near 50-Year Highs</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="506" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22104158/image-156-1024x506.png" alt="" class="wp-image-744985" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22104158/image-156-1024x506.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22104158/image-156-300x148.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22104158/image-156-768x380.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22104158/image-156-1536x759.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22104158/image-156.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">What&#8217;s Triggering The Coffee Price Spike? </h3>
The coffee market has seen supply risks materializing on its world&#8217;s top producer. 
Brazil's coffee production forecast have been downwardly revised in recent months amid weather disruptions hitting South America&#8217;s largest country. 
On Monday, Conab, Brazil's national supply agency, estimated the country's 2024 coffee harvest at 54.2 million 60kg bags, a 1.6% decline from the prior year's crop. 
The revision follows adverse weather in Minas Gerais, a key Arabica-producing region, that has constrained supply. Meanwhile, strong demand for Robusta beans, often used in instant coffee, has compounded price pressures.
In Australia, Restaurant and Cafe Association chief executive Wes Lambert said the cost of a coffee &#8220;could reach double digits&#8221; in major cities if bean prices remain elevated.
<h3 class="wp-block-heading">Starbucks' Hedging Strategy: A Safety Net?</h3>
Despite soaring coffee prices, Starbucks may be shielded from immediate cost increases. The Seattle-based company has long-term purchasing strategies as indicated by Bank of America.
As the world&#8217;s largest coffeehouse, Starbucks secures supply agreements more than a year in advance. The chain has a mix of fixed-price and price-to-be-fixed contracts.
Fixed-price contracts lock in costs upfront, while price-to-be-fixed agreements allow pricing flexibility until delivery. 
Starbucks relies on futures contracts and collars, which are derivative instruments that help stabilize price fluctuations, to hedge against volatile coffee costs. 
While Starbucks&#8217; hedging policies provide insulation, the company still supplements its inventory with purchase commitments, some of which remain exposed to the unpredictable swings in commodity prices. 
The question is whether sustained high prices could eventually seep into its cost structure.
Yet, Bank of America remains optimistic about Starbucks&#8217; outlook. &#8220;We believe SBUX&#8217;s brand remains fundamentally strong and there are significant opportunities to reallocate resources,&#8221; Senatore wrote in the note, maintaining a Buy rating with a $117 price target. 
Read now: 
<ul>
<li><a href="http://benzinga.com/etfs/emerging-market-etfs/25/01/43130930/trump-looking-at-10-tariff-on-china-starting-feb-1">Trump &#8216;Looking At&#8217; 10% Tariff On China Starting Feb. 1</a></li>
</ul>

Large Cap

Latin America

Global

Econ #s

Economics

SBUX

Coffee Prices Soar To Record Highs: Could Starbucks Face Margin Squeeze?

Investors with a lot of money to spend have taken a bearish stance on JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with JPM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for JPMorgan Chase.
This isn't normal.
The overall sentiment of these big-money traders is split between 46% bullish and 53%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $300,058, and 8 are calls, for a total amount of $855,065.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $195.0 to $300.0 for JPMorgan Chase over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in JPMorgan Chase's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to JPMorgan Chase's substantial trades, within a strike price spectrum from $195.0 to $300.0 over the preceding 30 days.
<h3>JPMorgan Chase Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737564406_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$40.4</td>
<td>$39.95</td>
<td>$39.95</td>
<td>$240.00</td>
<td>$515.3K</td>
<td>2.1K</td>
<td align="right">129</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$68.7</td>
<td>$68.2</td>
<td>$68.2</td>
<td>$195.00</td>
<td>$95.4K</td>
<td>436</td>
<td align="right">14</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.69</td>
<td>$1.65</td>
<td>$1.7</td>
<td>$250.00</td>
<td>$67.9K</td>
<td>1.2K</td>
<td align="right">929</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$13.5</td>
<td>$12.4</td>
<td>$12.7</td>
<td>$260.00</td>
<td>$63.5K</td>
<td>1.0K</td>
<td align="right">0</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$8.3</td>
<td>$8.1</td>
<td>$8.29</td>
<td>$265.00</td>
<td>$50.5K</td>
<td>344</td>
<td align="right">99</td>
</tr>
</tbody>
</table>

<h3>About JPMorgan Chase</h3>
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4.1 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
Following our analysis of the options activities associated with JPMorgan Chase, we pivot to a closer look at the company's own performance.
<h3>JPMorgan Chase's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 2,499,176, the JPM's price is down by -0.48%, now at $261.75. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 79 days.</li>
</ul>
<h3>What Analysts Are Saying About JPMorgan Chase</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $285.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on JPMorgan Chase, which currently sits at a price target of $330. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on JPMorgan Chase with a target price of $287. 
&#x2A; Maintaining their stance, an analyst from Keefe, Bruyette &amp; Woods continues to hold a Market Perform rating for JPMorgan Chase, targeting a price of $264. 
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on JPMorgan Chase, which currently sits at a price target of $268. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for JPMorgan Chase, targeting a price of $280. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Comments

IMV

News

Latest news for IMV (OTC:IMVIF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga